<DOC>
	<DOC>NCT00594464</DOC>
	<brief_summary>Evaluation of efficacy and safety on the use of rotigotine in patients suffering from Parkinson's Disease during and after surgery requiring general anaesthesia.</brief_summary>
	<brief_title>A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Subject has idiopathic Parkinson's disease (early or advancedstage), as defined by the cardinal sign bradykinesia, plus the presence of at least one of the following: resting tremor, rigidity, or postural instability and is without any other known or suspected cause of Parkinsonism. Subject is scheduled for an operation requiring general anesthesia. Subject has previously been treated with rotigotine. Subject has a history of significant skin hypersensitivity to adhesives or other transdermals or recent unresolved contact dermatitis or has a known allergy or hypersensitivity to rotigotine or to other components of the patch. Subject is scheduled for a surgical procedure (surgery per protocol(SPP)) that requires magnetic resonance imaging or cardioversion. Subject has a high probability to require extended postoperative ventilation (&gt; 24 hours). Subject has any medical condition that, in the opinion of the investigator, could jeopardize or compromise the subject's ability to participate in this trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>NEUPRO®</keyword>
	<keyword>Parkinson's Disease (PD)</keyword>
	<keyword>perioperative use</keyword>
	<keyword>anaesthesia,</keyword>
</DOC>